betamethasone
PolandDrugs containing this active substance
-
The medicinal product is used topically for the treatment of psoriasis of the hairy scalp, severe forms of seborrheic dermatitis, lichen planus, severe forms of allergic dermatitis, contact eczema of the hairy scalp, and lupus erythematosus.
Form: solution, topical
Active substance Dosage betamethasone 0,5 mg/g salicylic acid 20 mg/g ATC: D07XC01
Manufacturer: Jelfa Pharmaceutical Enterprise S.A.
-
It is intended for the topical treatment of inflammatory skin diseases that cause itching and respond to corticosteroid treatment.
Form: cream
Active substance Dosage betamethasone 0.5 mg/g ATC: D07AC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically for the treatment of skin diseases characterized by inflammation and itching, which respond to corticosteroid treatment.
Form: ointment
Active substance Dosage betamethasone 0.5 mg/g ATC: D07AC01
Manufacturer: Belupo s.r.o.
-
It is used topically for the treatment of skin diseases characterized by inflammation and itching, which respond to corticosteroid treatment.
Form: ointment
Active substance Dosage betamethasone 0.5 mg/g ATC: D07AC01
Manufacturer: Belupo s.r.o.
-
The medicine is used for the topical treatment of skin diseases complicated by bacterial infection and responsive to corticosteroid treatment. It is intended for persons over 13 years of age.
Form: ointment
Active substance Dosage betamethasone 0.5 mg/g gentamicin 1 mg/g ATC: D07CC01
Manufacturer: Belupo s.r.o.
-
It is used for the topical treatment of skin diseases that are complicated by bacterial infection and respond to corticosteroid treatment. It is intended for individuals over 13 years of age.
Form: ointment
Active substance Dosage betamethasone 0.5 mg/g gentamicin 1 mg/g ATC: D07CC01
Manufacturer: Belupo s.r.o.
-
The medicine is used for the topical treatment of skin diseases that respond to corticosteroid treatment and are additionally complicated by bacterial infection. It is intended for individuals over 13 years of age.
Form: cream
Active substance Dosage betamethasone 0.5 mg gentamicin 1 mg ATC: D07CC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically for the treatment of skin diseases complicated by bacterial infection and responsive to corticosteroid treatment. It is intended for individuals over 13 years of age.
Form: ointment
Active substance Dosage betamethasone 0,5 mg/g gentamicin 1 mg/g ATC: D07CC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Form: solution for skin
Active substance Dosage betamethasone 0.5 mg salicylic acid 20 mg ATC: D07XC01
Manufacturer: Belupo, s.r.o.
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Form: ointment
Active substance Dosage betamethasone 0.5 mg salicylic acid 30 mg ATC: D07XC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC: D07XC01
Manufacturer: Belupo s.r.o.
-
The ointment is intended for the topical treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC: D07XC01
Manufacturer: Belupo, s.r.o.
-
It is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Form: solution, topical
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 20 mg/g ATC: D07XC01
Manufacturer: Belupo s.r.o.
-
The medicinal product is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC: D07XC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically to treat skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Form: solution, topical
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 20 mg/g ATC: D07XC01
Manufacturer: Belupo s.r.o.
-
It is used for the topical treatment of scalp psoriasis in adults and mild to moderate plaque psoriasis on the body skin (other than the scalp).
Form: gel
Active substance Dosage calcipotriol 50 mcg/g betamethasone 0.5 mg/g ATC: D05AX52
Manufacturer: Aristo Pharma GmbH
-
It is used in the treatment of inflamed skin lesions (such as eczema or dermatitis) and in cases of bacterial skin infections.
Form: cream
Active substance Dosage fusidic acid 20 mg/g betamethasone 1 mg/g ATC: D07CC01
Manufacturer: Kymos, S.L.
-
It is used for the topical treatment of scalp psoriasis in adults and mild to moderate plaque psoriasis in adults (on the body skin, other than the scalp).
Form: gel
Active substance Dosage calcipotriol 50 mcg/g betamethasone 0.5 mg/g ATC: D05AX52
Manufacturer: C.P.M. ContractPharma GmbH
-
The medicine is used for the initial treatment of eczema or dermatitis that is accompanied by an infection with bacteria sensitive to fusidic acid.
Form: cream
Active substance Dosage fusidic acid 20.00 mg/g betamethasone 1.00 mg/g ATC: D07CC01
Manufacturer: mibe GmbH Pharmaceuticals
-
It is used in the treatment of fungal infections of the groin, perineum, feet, and non-hairy skin, as well as in cases of candidiasis accompanied by inflammation or allergic reactions.
Form: cream
Active substance Dosage betamethasone 0,500 mg clotrimazole up to 100 g ATC: D07BC01
Manufacturer: Organon Heist bv